Capricor Therapeutics issued a securities class action notice for investors who lost money after the stock plummeted 64%. Affected investors are instructed to contact BFA Law by September 28. While this is a legal/regulatory development rather than an operating update, it reinforces negative sentiment around the prior price decline and can pressure the shares in the near term.
Capricor Therapeutics issued a securities class action notice for investors who lost money after the stock plummeted 64%. Affected investors are instructed to contact BFA Law by September 28. While this is a legal/regulatory development rather than an operating update, it reinforces negative sentiment around the prior price decline and can pressure the shares in the near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately negative
Sentiment Score
-0.55
Ticker Sentiment
